Response to ustekinumab treatment in patients with systemic lupus erythematosus is linked to suppression of serum interferon gamma levels

ConclusionsThese data indicate an important role of IL ‐12 blockade in the mechanism of action of ustekinumab in SLE.

Source: Arthritis and Rheumatology - October 2, 2020 Category: Rheumatology Authors: Matteo Cesaroni, Loqmane Seridi, Matthew J. Loza, Jessica Schreiter, Kristen Sweet, Carol Franks, Keying Ma, Ashley Orillion, Kim Campbell, Robert Gordon, Patrick Branigan, Peter Lipsky, Ronald van Vollenhoven, Bevra H. Hahn, George C. Tsoko Tags: BRIEF REPORT Source Type: research